Cargando…

Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer

BACKGROUND: To investigate the mechanism by which apolipoprotein A1 (APOA1) enhances the resistance of cervical squamous carcinoma to platinum-based chemotherapy. METHODS: Two cervical squamous carcinoma cell lines (SiHa and Caski) overexpressing APOA1 were constructed, treated with carboplatin, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yue, Han, Su-Bin, Liu, Yang, Zhang, Jing-Jing, Wu, Yu-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009492/ https://www.ncbi.nlm.nih.gov/pubmed/35421932 http://dx.doi.org/10.1186/s12885-022-09528-x

Ejemplares similares

Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome
por: Wu, Yanhua, et al.
Publicado: (2016)

The Efficacy and Response Predictors of Platinum-Based Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
por: Huang, Yuhui, et al.
Publicado: (2020)

Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy
por: Wang, Yue-shen, et al.
Publicado: (2016)

RAD52 Variants Predict Platinum Resistance and Prognosis of Cervical Cancer
por: Shi, Ting-Yan, et al.
Publicado: (2012)

Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer
por: Yu, Xiao-Li, et al.
Publicado: (2021)

The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC)
por: Li, Zhuang-hua, et al.
Publicado: (2016)

Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer
por: Yang, Ling, et al.
Publicado: (2022)

Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
por: Zhu, Yunshu, et al.
Publicado: (2020)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)

Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men
por: Ma, Cheng, et al.
Publicado: (2015)

Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma
por: Wu, Haishan, et al.
Publicado: (2021)

Evaluating the association of APOA2 polymorphism with insulin resistance in adolescents
por: Zaki, Moushira Erfan, et al.
Publicado: (2014)

Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population
por: Fu, Qianxi, et al.
Publicado: (2015)

Ovarian cancer resistance to PARPi and platinum-containing chemotherapy
por: Summey, Rebekah, et al.
Publicado: (2022)

Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer
por: Zang, Hongjing, et al.
Publicado: (2017)

Association of BUD13-ZNF259-APOA5-APOA1-SIK3 cluster polymorphism in 11q23.3 and structure of APOA5 with increased plasma triglyceride levels in a Korean population
por: Kim, Han-Kyul, et al.
Publicado: (2019)

In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
por: Mellish, K. J., et al.
Publicado: (1993)

A long non-coding RNA, APOA4-AS, regulates APOA4 expression depending on HuR in mice
por: Qin, Wangshu, et al.
Publicado: (2016)

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.
por: Thyss, A., et al.
Publicado: (1986)

Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
por: Karageorgopoulou, Sofia, et al.
Publicado: (2017)

APOA1 Is a Novel Marker for Preeclampsia
por: Liu, Zhenzhen, et al.
Publicado: (2023)

Decreased expression of the APOA1–APOC3–APOA4 gene cluster is associated with risk of Alzheimer’s disease
por: Lin, Qiao, et al.
Publicado: (2015)

Influences of APOA5 Variants on Plasma Triglyceride Levels in Uyghur Population
por: Li, Shuyuan, et al.
Publicado: (2014)

Concurrent radiotherapy and weekly chemotherapy of 5-fluorouracil and platinum agents for postoperative locoregional recurrence of oesophageal squamous cell carcinoma
por: Zhang, Wen-Wen, et al.
Publicado: (2015)

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer
por: Nara, Katsuhiko, et al.
Publicado: (2023)

Comparative survival analysis of platinum‐based adjuvant chemotherapy for early‐stage squamous cell carcinoma and adenocarcinoma of the lung
por: Hsiao, Shih‐Hsin, et al.
Publicado: (2022)

Nomogram to Predict Treatment Outcome of Fluoropyrimidine/Platinum-Based Chemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
por: Jung, Hyun Ae, et al.
Publicado: (2013)

Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity
por: Yoo, Jeong-Ah, et al.
Publicado: (2015)

Plasma miR-32 levels in non-small cell lung cancer patients receiving platinum-based chemotherapy can predict the effectiveness and prognosis of chemotherapy
por: Xu, Shuyuan, et al.
Publicado: (2019)

APOA1 Level is Negatively Correlated with the Severity of COVID-19
por: Yu, Xiaosi, et al.
Publicado: (2022)

Association between the APOA2 rs3813627 Single Nucleotide Polymorphism and HDL and APOA1 Levels Through BMI
por: Boughanem, Hatim, et al.
Publicado: (2020)

The Variants at APOA1 and APOA4 Contribute to the Susceptibility of Schizophrenia With Inhibiting mRNA Expression in Peripheral Blood Leukocytes
por: Fan, Yao, et al.
Publicado: (2021)

SIDT2 Associates with Apolipoprotein A1 (ApoA1) and Facilitates ApoA1 Secretion in Hepatocytes
por: Sampieri, Alicia, et al.
Publicado: (2023)

Inhibition of BIRC2 Sensitizes α7-HPV-Related Cervical Squamous Cell Carcinoma to Chemotherapy
por: Lin, Chiao-Yun, et al.
Publicado: (2021)

Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
por: Kawano, Kouichiro, et al.
Publicado: (2015)

Human apoA-I[Lys107del] mutation affects lipid surface behavior of apoA-I and its ability to form large nascent HDL
por: Gorshkova, Irina N., et al.
Publicado: (2022)

Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer
por: WANG, YADI, et al.
Publicado: (2016)

Effect of XPC polymorphisms on the response to platinum-based chemotherapy: a meta-analysis
por: Xie, Chenyao, et al.
Publicado: (2019)

ApoA-1 in Diabetes: Damaged Goods
por: Ory, Daniel S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5dn9rtgq4p6bides0pr7c1so6f